ASCO Guideline Update: Management of advanced human epidermal growth factor receptor 2–positive breast cancer and brain metastases.
1 Jun, 2022 | 11:36h | UTC
Commentary on Twitter
? Just published in #JCO: Guideline update on management of advanced human epidermal growth factor receptor 2–positive #breastcancer and #brainmetastases.
Read more ➡️ https://t.co/fz0lfJE8zb #bcsm #btsm #brainmets pic.twitter.com/C7tyCsVGR7
— Journal of Clinical Oncology (@JCO_ASCO) May 31, 2022